Acquisition of Medicine Semaglutide Approved by Isp for Use in Obesity for Obesity Approach Strategy Managed From the S.s.o.
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The Service in this tender requires implementing the Obesity Approach strategy, which contemplates the delivery of Semaglutide medication in 4 injectable presentations approved by the ISP for use in Obesity, for use in PHC, and with partial deliveries in 2026 and April 2027.